James E. Flynn 13D and 13G filings for Singular Genomics Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 5:31 pm Sale | 2023-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 250,496 6.830% | -13,393 (-5.08%) | Filing |
| 2023-08-14 5:07 pm Sale | 2023-08-09 | 13G | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 263,889 7.400% | -35,474 (-11.85%) | Filing |
| 2023-02-10 2:29 pm Sale | 2022-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 299,362 9.070% | -5,372 (-1.76%) | Filing |
| 2021-06-03 4:49 pm Purchase | 2021-06-01 | 13G | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 304,734 12.890% | 304,734 (New Position) | Filing |